Invetech Co-Develops CellKey for MDS Sciex

Invetech, specialist in instrument development and custom automation which exhibits at Drug Discovery Technology & Development 2006 on booth #738, announces development of the unique CellKey™ technology. Successfully launched to market in September 2005, CellKey™, a high information secondary screening instrument employing Cellular Dielectric Spectroscopy (CDS), was completed within 21 months. Invetech was commissioned by MDS Sciex, to collaborate on development of the new CellKey™ technology.

The CellKey™ platform is a fully automated system for secondary screening laboratories and target validation. A unique technology for analysis, CellKey™ enables label-free and universal measurements of endogenous and transfected receptors, irrespective of their coupling mechanism. Kinetic measurements are taken in real-time with all wells of the microplate being read in parallel.

The collaboration allowed MDS Sciex to maximise its R&D by utilizing the capabilities of Invetech as its development partner.

Invetech, which exhibits at Discovery Technology & Development 2006, is participating in a seminar about this project at 9am, Wednesday 9 August. More information on the seminar is available at www.drugdisc.com. In addition, an indepth flyer on the collaboration is available free of charge on booth #738.

For more information about Invetech’s innovative instrument development techniques and custom automation services, please contact Invetech on Invetech@scottmail.co.uk, visit the website article webpage, phone East Coast US: +1 203 675 4502, West Coast US: +1 415 533 1958, or visit on booth #738 at Drug Discovery Technology and Development.